Srougi Victor, Tourinho-Barbosa Rafael R, Nunes-Silva Igor, Baghdadi Mohammed, Garcia-Barreras Silvia, Rembeyo Gregory, Eiffel Sophie S, Barret Eric, Rozet Francois, Galiano Marc, Sanchez-Salas Rafael, Cathelineau Xavier
1 Department of Urology, Institut Montsouris , Paris, France .
2 Division of Urology, University of Sao Paulo , Sao Paulo, Brazil .
J Endourol. 2017 Mar;31(3):229-237. doi: 10.1089/end.2016.0659. Epub 2017 Jan 19.
Prostate cancer (PCa) is stratified into different risk categories based on the patient's prognosis. High-risk disease was formerly characterized by an increased risk of metastasis and lethality, requiring complex treatments. Surgery was recently highlighted to have a pivotal role for the treatment of such cases, even as monotherapy. In the past, open radical prostatectomy was performed for most patients with high-risk PCa; however, robot-assisted radical prostatectomy (RARP) emerged as a reasonable option because it provided optimal outcomes for low- and intermediate-risk PCa. Robust studies are lacking to properly assess the role of RARP for high-risk PCa. We summarize this knowledge and present a literature review on the perioperative recovery and functional and oncologic outcomes of RARP for the treatment of patients with high-risk PCa.
前列腺癌(PCa)根据患者的预后被分为不同的风险类别。高危疾病以前的特征是转移和致死风险增加,需要复杂的治疗。最近有研究强调,手术,即使是作为单一疗法,在这类病例的治疗中也起着关键作用。过去,大多数高危PCa患者接受开放性根治性前列腺切除术;然而,机器人辅助根治性前列腺切除术(RARP)成为一种合理的选择,因为它为低危和中危PCa患者提供了最佳的治疗效果。目前缺乏有力的研究来正确评估RARP在高危PCa治疗中的作用。我们总结了这方面的知识,并对RARP治疗高危PCa患者的围手术期恢复、功能和肿瘤学结果进行了文献综述。